scholarly journals Chemetall Opens New Production Facility in the USA

2013 ◽  
Vol 6 (1) ◽  
pp. 4-4
2014 ◽  
Vol 18 (04) ◽  
pp. 19-23 ◽  

Solentim expands reach into China China approves biobased aviation fuel for commercial use Bayer to acquire Dihon Pharmaceutical Group Co., Ltd. in China Lilly and Novast expand state of the art manufacturing facility in Nantong, China TaiGen Biotechnology receives marketing approval from the Taiwan Food and Drug Administration for Taigexyn® in Taiwan Simulations Plus signs new partnership agreement in China Cardium changes name to Taxus Pharmaceuticals in connection with strategic collaboration with Shanxi Taxus Pharmaceuticals Applikon Biotechnology opens new production facility in Guangzhou, China


2018 ◽  
pp. 311-325
Author(s):  
Andrey V. Budanov

Introduction. The article is devoted to the problems of financing of the USSR of rocket production branch on the eve of the Caribbean Crisis. At the present stage it is necessary to consider possible negative consequences of development of defensive technologies not to repeat past mistakes and to avoid social and economic crises. Materials and Methods. To study the problem the author of the article uses the published declassified documents and for introduced for scientific use the first time. The methodological basis of this study is the theory of modernization, because it has essential informative and cognitive explanatory potential when studying history of Russia of the middle of the 20th century. The analysis of a problem on the basis of declassified data and theories has allowed to introduce the new facts into scientific circulation and to draw a number of valid conclusions. Results. In the late 1950th – the beginning of the 1960th bases of nuclear missile forces have been created in the Soviet Union. Existence of the advanced military technologies became one of the reasons of world recognition of the Soviet Union in the status of the great power. Strengthening of military power and arms race have led to financial and social problems. First of all, process has involved serious costs for development of military-industrial production and creation of the serving equipment. The financial costs were increased because of this situation. On the eve of the Caribbean Crisis the Soviet army has bought rocketry for 6 billion rubles. It is necessary to increase these costs approximately twice as for production of rocketry required to build new production capacities and starting objects. Discussion and Conclusions. In fact, the absence of private investors and producers forced at first to spend funds for creation of the production capacities making ballistic missiles, and then for purchasing of the products made by them. In this case the defect of the Soviet economic system at which the state has been forced to pay for missiles twice appeared. All costs were carried out at the expense of the state and society. The high cost of implementation of the Soviet rocket project has led to sharp deterioration in a social and economic situation in the country. For minimization of negative consequences it was necessary to reform the system of planning and management of rocket production, to organize the competition between the design organizations and also to refuse production of many samples of rocketry to concentrate financial reserves on creation of the most perspective systems. Nevertheless, valuable considerable expenses and efforts in the country the board which has allowed to strengthen defense capability of the Soviet Union has been created nuclear missile. During the Caribbean Crisis the governance of the USA has realized impossibility of a victory over the USSR in nuclear war. It has forced them to refuse aggressive foreign policy concerning the Soviet block that has led to discharge of international tension.


2005 ◽  
Vol 09 (11) ◽  
pp. 450-464

Bionomics Acquires Melbourne-based Iliad Chemicals. Cryptome Pharma and Xantos Biomedicine Join Forces to Validate Novel Cancer Lead. VioQuest's New Production Facility in China. AlphaRx Gains Access to Asian Markets Through Joint Venture with Basin Ltd. Emcure Pharma Cooperates with Iceland's Actavis Pharma. GSK and Japan's Eisai Pair Up to Sell Paritec in India. KV Pharma Invests $11.3 Million in Strides Arcolab. Lupin in Marketing Pact with Henry Schein. Sumitomo Pharma and Protez Pharma Announce Licensing Agreement on Breakthrough Antibiotic. Neuren Pharma — World Leader in Developing Treatment for Neurological Disorders. Singapore's A-bio Collaborates with Novo Nordisk. From Poisons to Pills. AbGenomics Licenses Antibody to Boehringer Ingelheim. Sino Cell and Taiwan Genome Sciences Team Up in Predictive Genetic Testing for the Taiwan Market. Agilent Technologies Sells US$4 million in Equipment to CDC.


Sign in / Sign up

Export Citation Format

Share Document